Short half-life problem and DPP-4 degradation

In a recent survey, three-in-four respondents said they would prefer a once‑daily oral pill over a weekly injection of GLP-1s. So why aren't there more oral options? By David S. Kim

Read all our work, for free, at press.asimov.com.